Verifying expressed transcript variants by detecting and assembling stretches of consecutive exons by Hsiao, Tzu-Hung et al.
Verifying expressed transcript variants by detecting








1,* and Konan Peck
2,*
1Departmant of Electrical Engineering, National Taiwan University, Taipei, Taiwan 106,
2Institute of Biomedical
Sciences, Academia Sinica, Taipei, Taiwan 115 and
3Research Center for Applied Sciences, Academia Sinica,
Taipei, Taiwan 115, ROC
Received February 9, 2010; Revised August 4, 2010; Accepted August 6, 2010
ABSTRACT
We herein describe an integrated system for the
high-throughput analysis of splicing events and the
identification of transcript variants. The system
resolves individual splicing events and elucidates
transcript variants via a pipeline that combines
aspects such as bioinformatic analysis, high-
throughput transcript variant amplification, and
high-resolution capillary electrophoresis. For the
14369 human genes known to have transcript
variants, minimal primer sets were designed to
amplify all transcript variants and examine all
splicing events; these have been archived in the
ASprimerDB database, which is newly described
herein. A high-throughput thermocycler, dubbed
GenTank, was developed to simultaneously
perform thousands of PCR amplifications.
Following the resolution of the various amplicons
by capillary gel electrophoresis, two new computer
programs, AmpliconViewer and VariantAssembler,
may be used to analyze the splicing events,
assemble the consecutive exons embodied by the
PCR amplicons, and distinguish expressed versus
putative transcript variants. This novel system not
only facilitates the validation of putative transcript
variants and the detection of novel transcript
variants, it also semi-quantitatively measures the
transcript variant expression levels of each gene.
To demonstrate the system’s capability, we used it
to resolve transcript variants yielded by single and
multiple splicing events, and to decipher the exon
connectivity of long transcripts.
INTRODUCTION
The generation of transcript variants by alternative
splicing is a common process in human gene expression;
indeed, >70% of human genes are known to express tran-
script variants (1). This mechanism allows a large reper-
toire of proteins to be generated from a limited number of
genes. Various studies have shown that the transcript
variants of a gene may have opposing roles, and alterna-
tive splicing is known to be a key factor in cancer progres-
sion. For example, Bcl-x, which is associated with cell
survival/apoptosis, has two isoforms, Bcl-xL and Bcl-xS.
The longer Bcl-xL isoform acts as an apoptotic inhibi-
tor, whereas the shorter form acts as an apoptotic activa-
tor (2).
Several approaches have been used to identify the
putative transcript variants of a given gene. Most such
approaches have been based on bioinformatic analysis
of expressed sequence tag (EST) sequences, in which a
gene’s EST sequences are aligned with its reference
genomic sequence and all possible splicing events
are identiﬁed from there (3–5). Another, higher-
throughput empirical strategy is microarray analysis
utilizing exon- or exon-exon junction-speciﬁc probes to
measure exon expression and identify splicing events; in
this method, the expression levels of individual exons and
the between-sample differential expression patterns of
splicing events are measured (1,6,7).
Recently, ‘next generation’ genome-sequencing
technologies have been used to uncover splicing events
in different organs and tissues (8–10). These genome-
sequencing technologies generate huge cDNA datasets
consisting of tens of millions of short sequencing
reads. These datasets provide comprehensive surveys
of splicing complexities in different tissues and con-
tain vast quantities of data on putative splice junctions
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number of putative splicing events that may be
identiﬁed in this way poses a great challenge for re-
searchers seeking to examine the expression of transcript
variants.
For example, in order to infer the biological functions
of a transcript variant, it is necessary to decipher the
exon connectivity of a variant, i.e. the composition and
order of exons of a variant, and assemble exons
into full-length transcripts. Methods to construct sets
of putative full-length transcript variants by permuting
the splicing events identiﬁed in EST libraries have
been reported (11). However, if a gene has two potential
splicing events, then the permutation method yields
four putative transcript variants, and so forth, often
creating a huge number of variants that must be identiﬁed.
In order to minimize the number of putative transcript
variants, several statistical methods have been used to
estimate the probability that each putative variant
encodes a viable transcript (5,12). In another study, an
algorithm was developed to predict the number of tran-
script variants and compute for the putative
full-length transcripts based on the hybridization signals
of an exon microarray (13). In other work, detailed
analyses of the hybridization signals from individual
exon-speciﬁc probes have been used to estimate the
putative expression proﬁles for sets of transcript variants
(14–16). The accuracy of this strategy is decreased,
however, if the splicing events are characterized
by complex connectivity or if novel transcript variants
are present. False predictions can be eliminated by
experimental approaches such as the use of RT–PCR
followed by electrophoresis to check the sizes of the
various amplicons. However, such studies employ PCR
primer pairs designed to amplify each exon–exon
junction of the gene under investigation, and this
strategy was found to require an average of 33 RT–PCR
reactions per gene (17).
Here, we describe an integrated system for high-
throughput transcript variant analysis that is capable of
resolving individual transcript variants by combining bio-
informatic analysis, RT-PCR, and capillary electrophor-
esis. This system not only detects stretches of consecutive
exons encompassing multiple splicing events, it also
semi-quantitatively measures the expression of each tran-
script variant. In brief, we collected all the splicing events
archived in various databases, and used this information
to design minimal PCR primers sets for each gene, such
that all the variously sized transcript variants could be
resolved by a multi-channel capillary electrophoresis in-
strument capable of carrying out thousands of reactions
per day. Capillary electrophoresis has been shown to be a
precise and efﬁcient method for detection of splicing
events (18). Our integrated system provides a high-
throughput solution for validating splicing events, exon
connectivity, and putative transcript variants that have
been identiﬁed with in silico approaches or empirical tech-
niques [e.g. exon microarrays and next-generation
sequencing (NGS)].
MATERIALS AND METHODS
Samples and PCR ampliﬁcation
Total RNA was derived from a lung adenocarcinoma
tissue sample purchased from Clontech (Mountain View,
CA). Fluorescent FAM dye-labeled reverse primers were
synthesized with an in-house constructed oligonucleotide
synthesizer, as previously described (19). Total RNA
(1mg) was reverse transcribed at 50 C for 1 h using
0.5pmol of oligo-dT primer and reverse transcriptase III
(Invitrogen, Carlsbad, CA) in a total volume of 11ml.
PCR was performed using 1ml of the reverse-transcribed
(RT) cDNA and a PCR reaction mixture containing
0.5mM of the paired primers, 0.24mM dNTPs, 20mM
Tris–HCl, pH 8.4, 50mM KCl, 1.4mM MgCl2, and
0.5 units of Platinum Taq DNA polymerase (Invitrogen)
in a total volume of 25ml. The PCR conditions were
as follows: initial denaturation at 94 C for 2min,
followed by 35 cycles of 94 C for 40 s, 57 C for 40s,
and 72 C for 2min, and a ﬁnal extension at 72 C for
10min. All primers used in this study are shown in
Supplementary Table S1.
The ‘GenTank’ high-throughput thermocycler
A high-throughput water immersion-based thermocycler,
dubbed ‘GenTank’, was constructed and employed to
perform large numbers of PCR ampliﬁcations. A descrip-
tion of the system, including schematic diagrams, can
be found in the Supplementary Data and online at
http://genestamp.ibms.sinica.edu.tw/GenTank/index.htm.
Brieﬂy, the system consists of the following: three water
tanks; a temperature-control module that sets the water
temperatures of the three tanks to the appropriate levels
for the various steps of PCR (i.e. denaturing, annealing
and primer extension); and a robotic module that moves
the PCR reaction vessels from one tank to the next. The
system is capable of simultaneously performing thousands
of PCR ampliﬁcations, or performing large-volume
(milliliter-scale) PCR ampliﬁcations.
Capillary electrophoresis and data analysis
The generated PCR amplicons were diluted 1:20 in Hi-Di
formamide solution (Applied Biosystems, Foster City,
CA) containing a 1:100 dilution of GeneScan 2500 size
standard (Applied Biosystems), and then separated using
an Applied Biosystems 3100 genetic analyzer or 3730xl
DNA analyzer. The capillaries were pre-run for 10min
before the samples were introduced by electrokinetic in-
jection for 15 s at 15kV. The electric ﬁeld strength of the
electrophoretic separations was set at 250 V/cm.
The resulting electropherograms were subjected to
peak detection using a software program written
in-house using Borland C+ + builder 6.0 (Borland,
Austin, TX). A detailed description of this soft-
ware, along with the software itself, is available online at
http://genestamp.ibms.sinica.edu.tw/AmpliconViewer/
index.htm. The length of each PCR amplicon was
determined by interpolation using curve-ﬁt data for the
electrophoresis size standard. First-order polynomial
curve-ﬁt data were used for amplicons <600bp, while
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larger amplicons (Supplementary Figure S4). The
amount of each amplicon was semi-quantitatively
determined based on the peak area.
For identiﬁcation of transcript variants for a given gene,
the amplicon lengths were compared with the lengths of
the putative transcript variants archived in the ASTD (20)
and Ensembl databases (21). Each variant in ASTD has a
TRAN-preﬁxed transcript number, whereas those in the
Ensembl database are designated by an ENST-preﬁxed
transcript number. A given amplicon was either matched
with the calculated length of an archived transcript
variant, or it was regarded as representing a novel variant.
We then used a newly developed software program,
which we called ‘VariantAssembler’, to identify long tran-
script variants that need to be resolved using multiple
PCR primer pairs and ampliﬁcations. VariantAssembler
was implemented in MATLAB (MathWorks, Natick,
MA), and the program codes are available online at
http://genestamp.ibms.sinica.edu.tw/VariantAssembler/
index.htm. The program measures the similarities between
the expression levels for the reference amplicons
generated by the ﬁrst PCR primer pair and the amplicons
generated by additional PCR primer pairs, with the goal
of identifying the variants expressed in the tested sample.
RESULTS
A high-throughput transcript variant analysis system
We constructed an integrated system for high-throughput
analysis of transcript variants. The system is based on
using PCR amplicon lengths to resolve putative transcript
variants. Figure 1 depicts the procedural pipeline, which
comprises six main components: (i) splice-site-ﬂanking
primer pair design; (ii) high-throughput oligonucleotide
synthesis; (iii) high-throughput thermocycling for RT–
PCR ampliﬁcation; (iv) multi-channel capillary electro-
phoretic separation; (v) PCR amplicon analysis; and (vi)
identiﬁcation and quantiﬁcation of transcript variants.
The splice-site-ﬂanking primer pairs were designed to
ﬂank the variable sequence regions of the putative tran-
script variants and generate PCR amplicons that each rep-
resented a distinct set of exon connectivity. Capillary
electrophoresis was used to separate the amplicons, and
the peak areas of the electropherogram were taken as rep-
resenting the expression levels of the relevant amplicons.
From there, the transcript variants were reconstructed
based on the obtained information on exon connectivity
and expression.
PCR primer pairs for transcript variant detection
A total of 16715 genes and 93441 putative transcript
variants were downloaded from the ASTD database for
analysis. Among the genes, 15098 had multiple tran-
scripts. To design splice-site-ﬂanking primer pairs, each
exon of the putative transcript variants was mapped to
its genomic coordinates, and the common and discordant
exons among the transcript variants of each gene were
identiﬁed (Figure 2). To minimize the number of primer
pairs needed for a given gene, we employed the optimal
PCR primer ﬂanking-region-selection scheme shown in
Figure 2. As can be seen in the ﬁgure, a given transcript
could be subject to various splicing events, such as exon
insertion, the use of an ambiguous boundary, and others.
The phrase ‘ambiguous boundary’ refers to either the start
or end position of an exon when sequence information is
inadequate to clearly identify one or both positions. Due
to the amplicon length limit of capillary electrophoresis in
achieving single-base separation, the primer pairs were
designed to yield PCR amplicons shorter than 1kbp. If
the predicted size of the PCR amplicon was longer than
1kbp, the PCR ﬂanking region was split into smaller frag-
ments that met this criterion (e.g. R2-1 and R2-2 in
Figure 2).
The majority of the transcript variants obtained from
ASTD were short EST fragments that contained only
partial information on splicing events. Among the 93441
transcript variants examined, 58% (54221 of 93441) were
shorter than 800bp, and 49726 (53%) comprised fewer
than ﬁve exons (Table 1). The primer design software suc-
cessfully generated 22307 PCR primer pairs for the 14369
genes (1.48 primer pairs per gene on average). Among the
14369 genes, 8680 required only one primer pair to ﬂank
all the variable splice sites, while 5689 required the use of
two or more primer pairs.
The ASprimerDB web user interface
A web user interface (http://genestamp.sinica.edu.tw/
ASprimer/index.htm) was established to provide detailed
information on the splice-site-ﬂanking primer pairs.
Figure 3 shows a sample web page that provides informa-
tion on the VEGFB gene. The query outputs include the
Ensembl gene ID, the Entrez gene ID, the gene symbol
and a brief description of the gene. The outputs also
include web links to detailed information on each tran-
script, as found in the Ensembl and RefSeq databases.
Two tables list information on the primers, including the
ID of the primer pair (Primer pair ID), the forward/
reverse primer sequences for each primer pair. The
second table lists the predicted lengths of the PCR
amplicons corresponding to the primer pair(s).
The transcript variants of VEGFB are displayed in the
sample web page, along with the exon connectivity of each
transcript variant and the size of each exon. Exons are
shown as boxes and connected by solid lines. The tran-
script variants are color-coded to mark the different
sources from which they were identiﬁed. The reference
transcript is shown in cyan. The transcript variants
obtained from the ASTD are shown in green and those
transcripts other than the reference transcript from the
Ensembl database are shown in blue. The transcript
variants from the H-Invitational Database (H-InvDB)
which provides curated annotation of human genes and
transcripts are shown in red and have HIT-preﬁxed tran-
script number (22). The web page provides a view of the
exon connectivity of each transcript variant, along with
the PCR primer annealing sites. The number of exons
and the starting and ending positions of each exon in
the transcript variants of VEFGB, along with their
sources, are presented in the table (bottom).
PAGE 3 OF 13 Nucleic Acids Research, 2010, Vol.38, No. 20 e187Figure 2. Schematic diagram illustrating the design of the splice-site-speciﬁc PCR primers. The reference transcript of a gene and its transcript
variants documented in the two utilized databases are aligned with their genomic coordinates in order to deﬁne the common and variable exons
present in the transcript variants. The canonical transcript of the Ensembl database is chosen as the reference transcript. The primers are located in
consensus exon regions ﬂanking the variable splice sites. The exon numbered with an ‘i’ sufﬁx designates the insertion of an alternative exon.
Numbered hyphenations indicate the presence of alternative splicing within the exons. For the sample transcripts shown in the ﬁgure, region R1
encompasses all the splicing events and can generate up to six possible transcript variants. If region R1 spans more than 1000bp, then it is divided
into two regions, R2-1 and R2-2, two primer pairs are used to ﬂank the variable region.
Figure 1. Flowchart of the high-throughput transcript variant proﬁling system. Putative splicing events are identiﬁed from databases and used to
design splice-site-ﬂanking primer sets. The primers are synthesized with a high-throughput oligonucleotide synthesizer and employed in a new
high-throughput thermocycler, dubbed GenTank, to generate amplicons representing the transcript variants. The PCR amplicons are separated
using a multi-channel capillary electrophoresis instrument, and the electropherograms are analyzed for semi-quantitative expression level measure-
ment of each amplicon, and for assembly of transcript variants.
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results may be found in a Supplementary Data, in Excel
format. We found that the results could be grouped into
three categories. These categories are listed and described
below, and selected examples are given to illustrate how
the method resolves the exon connectivity of transcript
variants.
Transcript variants resulting from one splicing event
The system identiﬁed numerous genes for which the ex-
pressed transcript variants arose from a single splicing
event. Examples of this category include two genes
known to be highly associated with cancer progression:
VEGFB and SPP1. VEGFB, which was reported to play
an important role in tumor angiogenesis, has three
isoforms in human astrocytoma (23). SPP1 (also known
as OPN) is a ligand of the cell-surface receptors, integrin
aVb3 and CD44v3-6; it is up-regulated in breast cancer
and contributes signiﬁcantly to cancer cell invasion. Two
transcript variants have been reported for SPP1, one
with a deletion of exon 4 and the other with a deletion
of exon 5 (24).
The ASTD database contained two transcript variants
for VEGFB, resulting from an alternative 50-donor
splicing event located in exon 6. The Ensembl database
contained only the transcript variant with a longer exon
6 (shown in Supplementary Data). The primer design
software generated forward and reverse primers located
in exons 1 and 7, respectively, to detect these splicing
events. As show in Figure 4A, the electropherogram
revealed that two peaks were obtained from the tested
lung cancer specimen. Measurement of the elution times
of the peaks allowed us to measure their sizes by curve
ﬁtting with respect to the size standards. Comparison with
the sizes of the archived transcripts allowed us to deter-
mine that one variant corresponded to transcript
ENST00000309422 in the Ensembl database, while the
other corresponded to TRAN00000073236 (containing
an alternative 50 donor splicing event in exon 6) in ASTD.
The second example, SPP1, had ﬁve putative transcript
variants listed in ASTD (see Supplementary Data); these
putative variants arose from different types of splicing
events, including exon insertion, exon deletion, an alter-
native 30-acceptor splicing site and the use of intron
retention. Some events had ambiguous boundaries
because the transcript sequences were incomplete in
ASTD. Four transcript variants were found in the
Ensembl database; these arose from exon deletion and
the use of intron retention. Only one transcript existed
in both databases: ENST00000395080 in the Ensembl
database corresponded to TRAN000000100841 in
ASTD. For empirical validation of the putative transcript
variants contained within the databases, our primer design
software generated forward and reverse primer pairs in the
consensus regions of exons 2 and 6, respectively. The ex-
perimental results revealed only two transcript variants
from the tested lung cancer sample (Figure 4B); they cor-
responded to ENST00000395080 and ENST00000237623,
and arose from exon 5 deletion splicing event.
Transcript variants resulting from multiple splicing events
The system was also capable of resolving transcript
variants resulting from complex combinations of splicing
events. Of the 278 genes that we tested for their transcript
variants in lung adenocarcinoma tissue, eight yielded three
or more transcript variants. One of these genes, ABCC1
(also known as MRP-1), has been reported to have
multiple transcript variants arising from complex combin-
ations of splicing events in ovarian cancer, and some of
these transcripts have been associated with multi-drug
resistance in cancer (25). Figure 5A shows an
electropherogram of the seven transcript variants our
system identiﬁed for ABCC1, along with their peak
areas (indicated beside each peak). Variants 1, 3 and 4
were found to be highly abundant, and the lowest versus
highest expression levels differed by more than 30-fold.
The longest transcript variant, variant 1 (corresponding
to ENST00000399410 in the Ensembl database), was used
as the reference transcript for our splicing analysis. The
results indicated that there were several possible splicing
events among these variants, namely single or combina-
torial deletions of exons 13, 16, 17 and 18. The transcript
sizes seen in the electropherogram arose via deletions of
exon 16, 17 and/or 18 (Figure 5A, yellow), with or without
deletion of exon 13 (Figure 5A, blue). By matching the
amplicon sizes with the predicted sizes of the different
exon deletion combinations, we determined the exon con-
nectivity of the transcript variants. For example, variants
6 and 7 both had deletions of exons 17 and 18 (Figure 5A,
red arrows), but variant 7 had an additional exon 13
deletion. Variants 3 and 5 both had deletions of exon
17, but variant 5 also had a deletion of exon 13
(Figure 5A, orange arrows). The exon connectivity of
variants 1, 2 and 4 are shown in the ﬁgure (Figure 5A,
blue arrows for variants 1 and 2, turquoise arrow for
variant 4). We did not observe any other exon deletion
event in the ABCC1 variants found in the tested sample.
To verify the accuracy of the exon connectivity
computed by matching the sizes of the empirically
determined amplicons with those of the putative transcript
variants of ABCC1, we examined the expression levels of
the transcript variants. First, the transcript variants were
classiﬁed into two categories, namely with (Figure 5B,
green column) or without (Figure 5B, blue column)
Table 1. Summary of transcript variants and splice-site-ﬂanking
primers
Number of genes 16715
Genes with multiple transcript variants 15098
Genes with splice-site-ﬂanking primers 14369
Number of transcript variants 93441
Variants shorter than 800bp 54211
Variants comprising less than ﬁve exons 49726
Number of primer pairs 22307
Number of genes requiring one splice-site-ﬂanking primer pair 8680
Number of genes requiring two splice-site-ﬂanking primer pairs 4075
Number of genes requiring three splice-site-ﬂanking primer pairs 1189
Number of genes requiring more than three primer pairs 425
Average number of splice-site-ﬂanking primer pairs per gene 1.48
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the expression levels of the exon-13-deleted variants were
consistently lower than those of variants that did not have
a deletion of exon 13. Four splicing events with combina-
torial deletions of exons 16, 17 and 18 (designated CSV1,
CSV2, CSV3 and CSV4) were identiﬁed from the experi-
mental data, and the transcript variants could be grouped
based on these splicing events (Figure 5B). Analysis of the
expression levels of the variants revealed that the
transcript variants in which exon 13 was deleted could
have the CSV1, CSV3, and CSV4 splicing events
(Figure 5B, left). Variant 6 (V6) and variant 7 (V7) both
had CSV1 splicing events that included deletion of exons
17 and 18. The CSV2 splicing event was only seen in tran-
script variants lacking exon 13. The only transcript variant
to exhibit the CSV2 splicing event was transcript variant 4.
The results from our expression analyses (Figure 5B) con-
ﬁrmed the exon connectivity determined by our system
Figure 3. Browser view of the ASprimerDB database entry for the VEGFB gene. The web browser shows information on the splice-site-speciﬁc PCR
primers, the exon connectivity of each transcript variant, the coordinates of the gene transcript, the lengths and locations of all exons, and the primer
locations. The 30-end positions of the forward and reverse primers are indicated by vertical green solid and dashed lines, respectively. The coordinates
of each exon are listed at the bottom.
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for ABCC1, variant 4 (with deletions of exons 16 and 17)
and variant 5 (with deletions of exons 13 and 17) were
reported in the literature but not documented in both
the Ensembl and ASTD databases. Variant 7 (with dele-
tions of exons 13, 17 and 18) is a novel variant that had
not previously been reported in either the literature or the
Ensembl and ASTD databases.
Collectively, these results show that our system can suc-
cessfully detect and resolve the exon connectivities of tran-
script variants based on size matching and expression level
veriﬁcation.
Transcript variants that must be obtained using multiple
PCR primer pairs
Capillary gel electrophoresis based DNA sequencing is the
currently available technology for resolving single base
difference in DNA fragments as large as 1kb. To distin-
guish transcript variants which have predicted amplicon
size larger than 1 kbp, it is necessary to use multiple
primer pairs to amplify the transcript variants for
analysis. The exon connectivity results are then
concatenated to assemble the full-length transcript.
ITGB4 is a long gene whose transcripts are longer than
5.8kbp. We found two transcript variants,
ENST00000200181 and ENST00000339591, in the
Ensembl database; and three transcript variants, TRAN
00000077450, TRAN00000077458 and TRAN
00000077454, in ASTD (Figure 6A). ENST00000200181
had an exon 33 deletion, while ENST00000339591 had an
exon 35 deletion; both have been described in the litera-
ture (6). TRAN00000077454 and TRAN00000077458
contained ambiguous exon boundaries and lacked
complete sequence information in ASTD. The gene has
a relatively long variable region, meaning that the use of
a single PCR primer pair would generate long amplicons
that would be difﬁcult to separate by high-resolution ca-
pillary electrophoresis. Thus, we designed two primer
pairs: primer pair 1 was located in exons 17 and
27 while primer pair 2 was located in exons 28 and 37 to
ﬂank the variable regions (Figure 6A).
We then used our system to elucidate the variants of this
gene in the tested lung cancer sample. As shown in
Figure 6B, primer pair 1 yielded amplicons 1 and 2, the
latter of which was shorter and encompassed the exon 18
deletion event documented in the TRAN00000077458
transcript variant (ASTD database). Primer pair 2
yielded three PCR amplicons reﬂecting deletions of
exons 33, 35 and 36. Based on analysis of the amplicon
lengths (Figure 6B) and exon connectivity,
ENST00000339591 was not detected in the tested
sample, but amplicon 3 (with deletion of exon 33) was
consistent with the computed length of ENST
00000200181, amplicon 4 corresponded to TRAN
00000077450, and amplicon 5 most likely corresponded
to TRAN00000077454. Although the sequence informa-
tion from ASTD was incomplete, primer pairs 1 and 2
appeared to amplify TRAN00000077458 and TRAN
00000077454, respectively. Regarding the expression
levels of the various ITGB4 transcript variants in the
lung cancer tissue specimen, primer pair 1 generated 94.3
and 5.7% of amplicons 1 and 2, respectively, while
the proportion of amplicons 3, 4 and 5 generated by
primer pair 2 was 2.9, 90.6 and 6.5%, respectively
(Figure 6C).
To decipher the exon connectivity, we permuted com-
binations of consecutive exons based on the possible
splicing events embodied by amplicons obtained from
the two PCR ampliﬁcations (Figure 6D). Variants 1, 2
and 3 could be generated by connecting amplicon 1 with
amplicons 3, 4 and 5, respectively, whereas variants 4, 5
and 6 were could be generated by connecting amplicon 2
with amplicons 3, 4 and 5, respectively. However,
although six putative transcript variants could be con-
structed, not all of these variants were expressed in the
tested sample. Based on the idea that the two amplicons
representing a single transcript variant should have similar
proportions in the PCR products (following normaliza-
tion across the different RT-PCR ampliﬁcations), we
used similarities in expression level to pair the amplicons
into potential sets of expressed variants.
Figure 4. Transcript variant analysis of VEGFB and SPP1. Every peak
in the electropherogram reﬂects a PCR amplicon comprising a stretch
of consecutive exons. The size of the amplicon is calculated with respect
to the curve-ﬁtted data of the size standard. (A) Transcript variant
analysis of the VEGFB gene. Two transcript variants were detected
and found to differ by an alternative 50 donor event; they were
identiﬁed as corresponding to ENST00000309422 and
TRAN00000073236 in the Ensembl and ASTD databases, respectively.
(B) Transcript variant analysis of the SPP1 gene. Two variants that
differ by an exon 5 deletion event were detected.
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sional similarities between the empirical electropherogram
data and putative transcript variants composed of differ-
ent amplicons, in order to identify the most probable
putative transcript variants that were expressed in the
test sample, as follows:





if x1   x2 jj < 0:1,
if x1   x2 jj   0:1,
where x1 and x2 are the product percentages represented
by the amplicons arising from primer pairs 1 and 2, re-
spectively. More speciﬁcally, x1 is the percentage of the
ﬁrst amplicon in the ﬁrst PCR reaction, and x2 is the
summed percentages of the amplicons in the second
PCR reaction that are connected to the amplicon
represented by x1. Using Figure 6D as an example, we
see that for transcript set S1, x1 is 94.3% (which is the
percentage of amplicon 1 in the results from the ﬁrst PCR)
and x2 is 93.5% (which is the summed percentages of
amplicons 3 and 4, which are connected with amplicon 1
to constitute transcript variants V1 and V2, respectively).
The measurement is based on the principle that the simi-
larity score, S(x1, x2), is close to 1 when x1 and x2 are
‘similar’, i.e. when the amplicons constituting the tran-
script variants have similar proportions in the products
generated by the two PCR ampliﬁcations. The transcript
variants contained within the transcript set having the
highest similarity score are considered to be expressed.
This calculation assumes that the number of expressed
transcripts does not exceed the maximum number of
amplicons detected in the PCR ampliﬁcations. In the
Figure 5. Transcript variant analysis of the ABCC1 gene, which has multiple splicing events. (A) Seven transcript variants of ABCC1 were detected.
The transcript variants documented in the Ensembl database are marked with the Ensembl accession number. The detected transcript variants are
shown by the blue electropherogram and the size ladders are shown by the green electropherogram. The colored arrows indicate the exon connect-
ivity of each transcript variant detected in the electropherogram. Based on informatic analysis, we determined that the ABCC1 variants arose from
an alternative exon 13 deletion (blue) and combinations of splicing events (CSVs; here, deletions) among exons 16, 17 and 18 (yellow). The
under-peak areas are shown beside each peak. (B) Analysis of the transcript variants with alternative exon 13 deletion and the CSVs. Based on
the alternative exon 13 deletion, the 7 variants can be grouped into 4 CSVs. The exon 13-deleted variants were all expressed at low levels.
e187 Nucleic Acids Research, 2010, Vol.38, No. 20 PAGE 8 OF 13Figure 6. Transcript variant analysis of ITGB4, which was ampliﬁed by two primer pairs. (A) The ITGB4 gene structure and alignment of the
transcript variants documented in the databases. Two exon stretches (yellow) were ampliﬁed to reveal the complete transcript variants of this long
(5.8 kbp) gene. (B) Electropherograms of the amplicons derived from these two PCR ampliﬁcations using DNA from a lung cancer specimen. The
ﬁrst ampliﬁcation generated amplicons 1 and 2, while the second generated amplicons 3, 4 and 5. The expression percentages for each of these PCR
amplicons are denoted in the ﬁgures. (C) The exon stretches encompassed by each amplicon, and their expression percentages in the products of the
two PCR ampliﬁcations. (D) Six putative variants were assembled by permuting the exon stretches generated by the two PCR ampliﬁcation reactions.
Six transcript sets (S1–S6), each consisting of three putative transcript variants, were composed and used to identify which transcript variants could
account for the peaks observed in the electropherograms. (E) Identiﬁcation of the transcript variants expressed in the test sample. The left panel
shows an expression pattern comparison between reference amplicons 1 and 2 and the expression patterns of the transcript sets. The colored bars
indicate the expression percentages of each amplicon. The dark and light gray bars indicate the expression percentages of the amplicons from the
second PCR in association with those of amplicons 1 and 2, respectively. An expression pattern similarity score was calculated for each transcript set;
the results are shown on the right. The upper abscissa indicates the expression percentage of the amplicons from the second PCR connected with
amplicon 1, while the lower abscissa indicates the expression percentage connected with amplicon 2. The ordinate indicates the similarity score.
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generated (in this case, by primer pair 2). Six possible ex-
pressed transcript sets consisting of three transcript
variants each (labeled S1–S6) were generated from the
putative transcript variants shown in Figure 6D. Taking
transcript set S1 (consisting of V1, V2 and V6) as an
example, we see that in the ﬁrst PCR reaction both V1
and V2 would yield amplicon 1, which comprised 94.3%
of the empirical yield, whereas V6 would yield amplicon 2,
which comprised 5.7% of the PCR product generated by
primer pair 1. In the second PCR ampliﬁcation, V1 and
the V2 would yield amplicons 3 and 4, respectively, which
together contributed 93.5% of the yield. V6 was calculated
separately from the above two variants because it was
connected with amplicon 2; in this case, the second PCR
reaction would yield amplicon 5, which comprised 6.5%
of the generated PCR product.
We then performed this calculation for all six possible
transcript sets. As shown in Figure 6E (left panel), tran-
script sets S1, S2 and S5 have summed expression percent-
ages that are fairly similar to the empirical results for
amplicon 1 (dark gray) and amplicon 2 (light gray).
Computation of similarity scores for the expression
patterns manifested by six transcript sets using the above
formula yielded similarity scores for S1, S2 and S5 of 0.92,
0.72 and 0.63, respectively. Based on this score, we
concluded that transcript variants V1, V2 and V6 (corres-
ponding to set S1) of ITGB4 were expressed in the tested
tumor specimen.
DISCUSSION
This report describes a novel integrated system for empir-
ically detecting and verifying putative transcript variants.
PCR primers that ﬂank the variable regions of transcript
variants (and thus encompass the possible splicing events)
are used to amplify the variants, and a high-resolution
capillary-based DNA sequencer is used to discriminate
among transcript variants whose sequences may differ
by as little as a single base. The system was able to
detect two expressed transcript variants for each of two
exemplar genes (VEGFB and SPP1), and correctly identify
these variants from the ASTD and Ensembl databases. In
addition, the system could detect two different types of
alternative splicing event within these two genes (e.g. an
alternative 50 donor site and exon deletion) based solely on
the amplicon length. Thus, the system allows simultaneous
detection of various splicing patterns among expressed
transcript variants.
Although the primer design described herein was based
on documented transcript variants, this system is not
limited to known variants. On the contrary, the system
can detect novel transcript variants, as demonstrated by
the identiﬁcation of a novel transcript variant of ABCC1.
The transcript variants of ABCC1 were covered using a
single primer pair encompassing combinatorial splicing
events (i.e. various deletions of exons 13, 16, 17 and 18).
By considering both the sizes and quantities of PCR
product represented by the various amplicons, the
system effectively resolved the complex exon connectivity
represented by the transcripts of ABCC1 and determined
that seven transcript variants were expressed in the tested
sample.
Rather than detecting the expressional variations
among individual exons, as is done in exon microarray
experiments, our system measures the expressional vari-
ations among consecutive stretches of exons. We found
that the transcript variants of  60% (8680/14369) of
the examined genes could be resolved using a single
PCR primer pair, and 89% (12755/14369) genes could
be resolved using one or two primer pairs. On average,
only 1.48 primers were required per gene. In cases for
which a single primer pair was sufﬁcient, each amplicon
peak represented a single transcript variant, and the peak
area could be quantitatively estimated as the expression
level. For more complex cases, such as that of ITGB4, the
expression patterns of consecutive exon stretches were
aligned to assemble the full array of transcript variants,
and expression pattern similarity scores were computed
for each transcript set and used to identify the expressed
variants.
The exon connectivity of each gene transcript deter-
mines whether the encoded protein contains a frame
shift or premature stop codon, whether it could be vulner-
able to nonsense-mediated decay, and/or if it contains
changes that affect the functional domains of the
protein. Bioinformatic analysis of EST libraries can
provide an initial blueprint of splicing events, but it is
difﬁcult to resolve the exon connectivity of a full transcript
from those based on EST sequences, which are typically
short. Some studies have listed all of the possible tran-
script variants that may be generated from EST alignment
(26), but consideration of all possible combinations of
splice events generates a huge number of putative tran-
script variants. Several other studies have applied con-
straints, for example by setting a threshold to limit the
number of the aligned EST or mRNA sequences (5,27).
In addition, probability models have been employed to
calculate maximum likelihoods from the aligned EST
sets, in order to identify transcript variants that have
higher possibilities of being expressed (12).
Our method improves on these previous efforts by
integrating high-throughput in silico and empirical
approaches. The empirical veriﬁcation minimizes the
number of putative transcript variants and identiﬁes
those that are truly expressed in a given sample. It does
so by considering both the connectivity of the amplicons
and their expression patterns in the tested sample.
Expression pattern similarity based on the abundance of
variant transcripts is important in determining which ex-
pression pattern (transcript set) is most likely to be real.
However, the abundance of variants is not the only
relevant parameter. Our method assumes a maximum
number of transcript variants based on a count of
amplicon peaks in the electropherogram. A simulation is
performed to assess the accuracy of this assumption, using
Bayesian probability theory. The transcript variants
forming the expression pattern with the highest similarity
score are identiﬁed as expressed (see the Supplementary
Data for more details). In the case of ITGB4, for example,
the computation assumed that there was a maximum of
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simulation showed that the accuracy of this prediction was
97.6%. Although it is formally possible that ITGB4 had
more than three transcript variants in the tested sample,
the empirical electropherogram data show that the expres-
sion of any additional transcript variant was insigniﬁcant.
To verify this contention, we determined the detection
limit of the system. In the case of ITGB4 of Figure 6B,
the signal-to-noise (S/N) ratio of amplicon 4 was 931.
By setting the detection limit at an S/N ratio of 3, the
limit was thus 1/310 (0.3%) for this most abundant
amplicon of ITGB4.
Figure 6 demonstrates how the VariantAssembler
program assembles and identiﬁes the transcript variants
expressed in a test sample. Long transcript variants
requiring three or more primer pairs are assembled
through serial concatenation of the variant assembly
results. As shown in Supplementary Figure S6, our
method showed that V1, V2 and V6 of ITGB4 were
expressed in the test sample, and further indicated the
expression level of each transcript variant.
VariantAssembler uses the transcript variants and their
expression levels identiﬁed from the ﬁrst and second
PCRs (e.g. the V1, V2 and V6 in Supplementary Figure
S6) as the x1 inputs. In cases where a third primer pair is
used, VariantAssembler uses the amplicons generated by
the third PCR, along with their quantities (taken from the
electropherogram), as inputs for x2. By serially inputting
the information from the various PCR ampliﬁcations,
VariantAssembler can resolve the full-length transcript
variants expressed in a given test sample.
It should be noted that the method does not determine
the exact transcript variants present in a test sample under
an extreme condition, which is all amplicons have the
same value of expression percentage and the number of
amplicons generated by every primer pair in a multi-
primer pair ampliﬁcation is the same. For examples,
50/50 for two amplicons generated by every primer pair
or 33/33/33 for three amplicons generated by every primer
pair in the ampliﬁcation set (see the Supplementary Data
for more details). Long-range PCR ampliﬁcation and
sequencing would be the way to resolve the above situ-
ation. However, with a detection limit of 0.3% expression
percentage as determined in Figure 6, the situation of
having amplicons with indistinguishably same expression
percentage is rare.
Two splicing event types are not included in this report:
the use of alternative transcript start sites, and alternative
polyadenylation. These two types of alternative splicing
events generate transcript variants that lack the regions
required to design 50-o r3 0-end primers to ﬂank the
variable region for ampliﬁcation. These two types of
splicing events are solved by designing one primer in the
common region and a speciﬁc primer for each putative
transcript variant.
The empirical exon microarray experiments have been
widely used to measure the expression of exons and detect
splicing events. However, it has proven difﬁcult to verify
these transcript-speciﬁc expression results. For example,
qPCR is not adequate to resolve the amplicons, and
RT–PCR followed by agarose gel electrophoresis is time
consuming and labor intensive. On the other hand, high
throughput sequencing using NGS methods generates
millions of short reads with lengths of a few hundred
bases at best. As with an exon microarray, the NGS
methods detect splicing events and identify putative tran-
script variants that need to be veriﬁed for correct
assembly.
To fulﬁl veriﬁcation goals, the system has to be able to
detect transcript variants that are incompletely annotated
in the databases. A simulation was performed to verify the
robustness of the method when dealing with incomplete
annotation. Exons were randomly removed from the an-
notation. The results are shown in a supplemental data ﬁle
(Supplementary Figure S8). In brief, by using the SPP1,
VEGFB, ABCC1 and ITGB4 genes discussed in the
present report as examples, the results show that our
method can identify novel splicing events or exons by
examining length discrepancies between empirical and pre-
dicted PCR amplicons.
The system is also able to detect novel splicing events
other than exon-skipping or deletion because such events
are revealed by length discrepancies between empirically
veriﬁed transcript variants and variants annotated in the
databases. However, to conﬁrm or assemble putative
variant transcripts identiﬁed by methods other than the
NGS approach (e.g. using RT–PCR), additional
sequence information may be needed to pinpoint novel
splicing events. The enhanced sequence information
provided by the NGS method aids in the resolution of
transcript variants resulting from mutually exclusive
exon splicing events within a gene, which might yield
amplicons of the same length. To estimate the probability
of encountering such a situation, we analyzed putative
splicing events in the ASTD database that would
generate amplicons of the same length for any particular
gene, and found that this scenario is rare. Of 93441
putative transcript variants derived from 16715 genes
using 78165 putative splicing events in the ASTD
database, 49 genes would yield two transcript variants
embodied by amplicons of the same length because of
the presence of 56 mutually exclusive exon splicing
events (0.07%), and 22 genes (0.13%) would yield two
transcripts embodied by amplicons of the same length
because two independent exon-skipping events would be
expected. These genes are tabulated in a Supplemental
Data, in Excel format. Furthermore, as it is known that
different tissues may have different expressed transcript
variants, the probabilities of encountering the scenarios
outlined above are much less than the calculated percent-
ages when transcript variants of a gene are studied in any
particular type of tissue. Therefore, our method is applic-
able to more than 99% of genes in the ASTD database,
and accurately veriﬁes putative transcript variants sug-
gested by methods that lack sequence information on
splicing events.
Our new method provides a new means to rapidly
identify and/or validate the differentially expressed tran-
script variants revealed by exon microarray and NGS
data. The PCR primer pairs that may be used for the
genes currently known to have transcript variants are
archived in the database developed for this study, and
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available. Although the GenTank high-throughput
thermocycler is not commercially available, its working
principle is straightforward and information on construct-
ing the instrument is provided in the supplementary ﬁle.
This report not only describes a pipeline of experimental
procedures and instruments, it also provides the utilized
software. Users can visualize the primer locations, tran-
script intron–exon structures, exon connectivity, exon
lengths and other information using the ASprimerDB
database and its web interface. The peak-detection
program, AmpliconViewer, may be used to analyze the
peak location and peak area in the electropherogram.
The VariantAssembler program may be used to calculate
expression pattern similarity scores and identify the ex-
pressed versus putative transcript variants for genes with
long transcript variants or complex splicing events. These
tools will greatly facilitate the work of researchers who are
interested in studying transcript variants. Our system is
capable of performing more than 2000 reactions in a
day. Using integrated technologies that combine primer
design, high-throughput oligonucleotide synthesis,
high-throughput GenTank thermocycling, capillary
electrophoresis-based DNA sequencing and data-
processing software, our novel system can be used to com-
prehensively analyze the alternative splicing patterns of
thousands of genes in a short time.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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